GlobeNewsWire
03 Jul 2026, 18:21 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
GeneDx Holdings recorded a $31.2 million impairment charge related to its Fabric Genomics acquisition, representing 94% of the original purchase price. — A massive write-down of a core acquisition suggests significant overpayment and failure of the strategic growth thesis.
-0.90GeneDx slashed its 2026 revenue guidance by 12% and lowered growth expectations for exome and genome revenue to 'at least 20%'. — Direct reduction in forward-looking revenue guidance typically triggers immediate downward valuation adjustments.
-0.80The company experienced a tenfold increase in net loss for Q1 2026 compared to the previous year. — Rapidly accelerating losses indicate deteriorating operational efficiency and financial instability.
-0.70Continue reading
6 related stories
Top 3 movers · tap to explore
Hagens Berman is investigating claims for a securities class action lawsuit alleging GeneDx misled investors regarding the Fabric Genomics acquisition. — Legal action and fraud allegations introduce significant regulatory risk and potential future liabilities.
-0.50GeneDx has appointed a new President, Mark Gardner, following a 49% stock price collapse. — Leadership changes can be a positive signal for a turnaround, but here it is tied to a period of failure.
+0.10Which stocks this story touches
The company is facing a securities class action lawsuit following a massive impairment charge, dismal earnings, and a 49% stock collapse.
The company is mentioned in the context of investors suffering losses due to allegedly misleading financial statements.
The company is mentioned in the context of investors suffering losses due to allegedly misleading financial statements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
7h ago
